Counterpoint Quantitative Equity Etf Annual Yield
| CPAI Etf | USD 41.26 0.50 1.23% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Counterpoint Quantitative's long-term financial health and intrinsic value.
Counterpoint | Build AI portfolio with Counterpoint Etf |
Counterpoint Quantitative Equity ETF Annual Yield Analysis
Counterpoint Quantitative's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Counterpoint Quantitative Annual Yield | 0.0006 % |
Most of Counterpoint Quantitative's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Counterpoint Quantitative Equity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Counterpoint Quantitative Equity has an Annual Yield of 6.0E-4%. This is much higher than that of the Health Care Providers & Services family and significantly higher than that of the Mid-Cap Blend category. The annual yield for all United States etfs is notably lower than that of the firm.
Counterpoint Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Counterpoint Quantitative's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Counterpoint Quantitative could also be used in its relative valuation, which is a method of valuing Counterpoint Quantitative by comparing valuation metrics of similar companies.Counterpoint Quantitative is currently under evaluation in annual yield as compared to similar ETFs.
Counterpoint Fundamentals
| Return On Asset | -13.96 | |||
| Current Valuation | 855.13 K | |||
| Shares Outstanding | 121.81 M | |||
| Shares Owned By Insiders | 64.79 % | |||
| Net Income | (5.85 M) | |||
| Cash And Equivalents | 5.29 K | |||
| Total Debt | 115.25 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (72.58 K) | |||
| Beta | -0.19 | |||
| Market Capitalization | 855.13 K | |||
| Total Asset | 27.76 K | |||
| Retained Earnings | (7.49 M) | |||
| Working Capital | (2.32 M) | |||
| Current Asset | 20 K | |||
| Current Liabilities | 2.34 M | |||
| Annual Yield | 0.0006 % | |||
| One Year Return | 13.60 % | |||
| Net Asset | 27.76 K |
About Counterpoint Quantitative Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Counterpoint Quantitative Equity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Counterpoint Quantitative using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Counterpoint Quantitative Equity based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price | |
| PRFDX | T Rowe Price | |
| RPBAX | T Rowe Price |
Check out Counterpoint Quantitative Piotroski F Score and Counterpoint Quantitative Altman Z Score analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
The market value of Counterpoint Quantitative is measured differently than its book value, which is the value of Counterpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Counterpoint Quantitative's value that differs from its market value or its book value, called intrinsic value, which is Counterpoint Quantitative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Counterpoint Quantitative's market value can be influenced by many factors that don't directly affect Counterpoint Quantitative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Counterpoint Quantitative's value and its price as these two are different measures arrived at by different means. Investors typically determine if Counterpoint Quantitative is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Counterpoint Quantitative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.